Menu
Maverick Therapeutics and Takeda Announce Five-year Collaboration to Advance T-Cell Engagement ...
- Takeda Invests $125 Million in Maverick, Including Exclusive Option-to-Acquire -
(BUSINESS WIRE)-- Maverick Therapeutics Inc., an MPM Capital portfolio company, and Takeda Pharmaceutical Company Limited (TSE:4502) announced today that they have entered a collaboration to develop Maverick's T-cell engagement platform created specifically to improve the utility of T-cell redirection therapy for the treatment of cancer. ...
Source : http://me-newswire.net//news/19339/en...
Dans la même rubrique :
Mercredi 19 Novembre 2025 - 15:00 Algérie : la BAD salue les grands chantiers lancés |
Mercredi 5 Novembre 2025 - 18:21 Tchad : Star Oil Tchad et Airtel Money s'allient pour accélérer l'inclusion financière |
Mardi 28 Octobre 2025 - 19:45 Tchad : Atelier de Formation sur l'Utilisation des Images par le Volet des Standards des Ménages (EHCVM) |
